- Captive
-
Smith BR
- KMID: 2537203
- Tuberc Respir Dis.
- 2023 Jan;86(1):57-58.
- doi: 10.4046/trd.2022.0130
-
- CITED
-
- Close
- SHARE
-
- Close
- Definition of Chronic Obstructive Pulmonary Disease Exacerbation: The Essentials of the Rome Proposal
-
Oh YM
- KMID: 2537205
- Tuberc Respir Dis.
- 2023 Jan;86(1):61-62.
- doi: 10.4046/trd.2022.0119
-
- CITED
-
- Close
- SHARE
-
- Close
- Early Use of High Flow Nasal Cannula in Postextubation Period: Can It Reduce Reintubation Rate?
-
Mukherjee P, Mandal M, Esquinas AM
- KMID: 2537206
- Tuberc Respir Dis.
- 2023 Jan;86(1):63-64.
- doi: 10.4046/trd.2022.0113
-
- CITED
-
- Close
- SHARE
-
- Close
- Early Use of High-Flow Nasal Cannula in Postextubation Period: Can It Reduce Reintubation Rate? Authors’ Reply
-
Sim JK, Lee YS
- KMID: 2537207
- Tuberc Respir Dis.
- 2023 Jan;86(1):65-66.
- doi: 10.4046/trd.2022.0161
-
- CITED
-
- Close
- SHARE
-
- Close
- Mounier-Kuhn Syndrome
-
Ayub II, Vengadakrishnan K
- KMID: 2537204
- Tuberc Respir Dis.
- 2023 Jan;86(1):59-60.
- doi: 10.4046/trd.2022.0123
-
- CITED
-
- Close
- SHARE
-
- Close
- Tuberculosis: Republic of Korea, 2021
-
Min J, Kim HW, Kim JS
- KMID: 2537208
- Tuberc Respir Dis.
- 2023 Jan;86(1):67-69.
- doi: 10.4046/trd.2022.0111
-
- CITED
-
- Close
- SHARE
-
- Close
- Review of Internet of Things-Based Artificial Intelligence Analysis Method through Real-Time Indoor Air Quality and Health Effect Monitoring: Focusing on Indoor Air Pollution That Are Harmful to the Respiratory Organ
-
Mun E, Cho J
- KMID: 2537200
- Tuberc Respir Dis.
- 2023 Jan;86(1):23-32.
- doi: 10.4046/trd.2022.0087
Everyone is aware that air and environmental pollutants are harmful to health. Among them, indoor air quality directly affects physical health, such as respiratory rather than outdoor air. However, studies... -
- CITED
-
- Close
- SHARE
-
- Close
- Update on Adjuvant Treatment in Resectable Non-Small Cell Lung Cancer and Potential Biomarkers Predicting Postoperative Relapse
-
Lim JU
- KMID: 2537199
- Tuberc Respir Dis.
- 2023 Jan;86(1):14-22.
- doi: 10.4046/trd.2022.0081
A significant proportion of patients with non-small cell lung cancer (NSCLC) is diagnosed in the early and resectable stage. Despite the use of platinum-based adjuvant chemotherapy, there was only a... -
- CITED
-
- Close
- SHARE
-
- Close
- New Targeted Therapy for Non-Small Cell Lung Cancer
-
Chung EK, Yong SH, Lee EH, Kim EY, Chang YS, Lee SH
- KMID: 2537198
- Tuberc Respir Dis.
- 2023 Jan;86(1):1-13.
- doi: 10.4046/trd.2022.0066
Lung cancer ranks first in cancer mortality in Korea and cancer incidence in Korean men. More than half of Korean lung cancer patients undergo chemotherapy, including adjuvant therapy. Cytotoxic agents,... -
- CITED
-
- Close
- SHARE
-
- Close
- Isolation and Antimicrobial Susceptibility of Nontuberculous Mycobacteria in a Tertiary Hospital in Korea, 2016 to 2020
-
Kim KJ, Oh SH, Jeon D, Chang CL
- KMID: 2537202
- Tuberc Respir Dis.
- 2023 Jan;86(1):47-56.
- doi: 10.4046/trd.2022.0115
Background: There is a global increase in isolation of nontuberculous mycobacteria (NTM). The aim of the study was to analyze longitudinal trends of NTM identification and pattern of antimicrobial susceptibility... -
- CITED
-
- Close
- SHARE
-
- Close
- An Open-Label, Multicentre, Observational, Post-Marketing Study to Monitor the Safety and Effectiveness of Umeclidinium/Vilanterol in Korean Patients
-
Cho EY, Cho JE, Lee EB, Yoo SS, Chang JH
- KMID: 2537201
- Tuberc Respir Dis.
- 2023 Jan;86(1):33-46.
- doi: 10.4046/trd.2022.0055
Background: Umeclidinium/vilanterol (UMEC/VI; ANORO ELLIPTA, GSK) is a commonly used dual bronchodilator. This study evaluated the safety and effectiveness of UMEC/VI in Korean patients with chronic obstructive pulmonary disease (COPD)... -
- CITED
-
- Close
- SHARE
-
- Close
